share_log

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities-Director Truex Samantha

Avalo Therapeutics | 3: Initial statement of beneficial ownership of securities

Avalo Therapeutics | 3：首次持股聲明
SEC announcement ·  04/03 16:13
Moomoo AI 已提取核心訊息
Samantha Truex, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, by Donald R. Reynolds by power of attorney, indicates that no securities are beneficially owned. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 and is a standard requirement for directors and significant shareholders to report their ownership of a company's securities.
Samantha Truex, a director and 10% owner of Avalo Therapeutics, Inc., has filed an Initial Statement of Beneficial Ownership of Securities with the SEC, as per a Form 3 submission dated March 28, 2024. The form, which was signed on April 3, 2024, by Donald R. Reynolds by power of attorney, indicates that no securities are beneficially owned. This filing is in accordance with Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 and is a standard requirement for directors and significant shareholders to report their ownership of a company's securities.
根據2024年3月28日提交的表格3，Avalo Therapeutics, Inc. 的董事兼10％所有者薩曼莎·特魯克斯已向美國證券交易委員會提交了初步的證券實益擁有權聲明。該表格由唐納德·雷諾茲於2024年4月3日通過委託書簽署，表明沒有實益持有證券。該文件符合1934年《證券交易法》第16（a）條或1940年《投資公司法》第30（h）條，是董事和大股東報告公司證券所有權的標準要求。
根據2024年3月28日提交的表格3，Avalo Therapeutics, Inc. 的董事兼10％所有者薩曼莎·特魯克斯已向美國證券交易委員會提交了初步的證券實益擁有權聲明。該表格由唐納德·雷諾茲於2024年4月3日通過委託書簽署，表明沒有實益持有證券。該文件符合1934年《證券交易法》第16（a）條或1940年《投資公司法》第30（h）條，是董事和大股東報告公司證券所有權的標準要求。
有用
沒用

該公告為獨立文件：

獨立文件1  查看翻譯

獨立文件2  查看翻譯

声明：本內容僅用作提供資訊及教育之目的，不構成對任何特定投資或投資策略的推薦或認可。 更多信息